Abstract:A novel and robust electrochemical sensing tool for the determination of vismodegib (VIS), an anticancer drug, has been developed by integrating the selective recognition capabilities of molecularly imprinted polymer (MIP) and the sensitivity enhancement capability of metal-organic framework (MOF). Prior to this step, the electrochemical behavior of VIS was investigated using a bare glassy carbon electrode (GCE). It was observed that in 0.5 M H2SO4 solution as electrolyte, VIS has an oxidation peak around 1.3 V and the oxidation mechanism is diffusion controlled. The determination of VIS in a standard solution using a bare GCE showed a linear response in the concentration range from 2.5 μM to 100 μM, with a limit of detection (LOD) of 0.75 μM. Since sufficient sensitivity and selectivity could not be achieved with bare GCE, a MIP sensor was developed in the next step of the study. For this purpose, the GCE surface was first modified by drop casting with as-synthesized Co-MOF. Subsequently, a MIP network was synthesized via a thermal polymerization approach using 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as monomer and VIS as template. MOFs are ideal electrode materials due to their controllable and diverse morphologies and modifiable surface properties. These characteristics enable the development of MIPs with more homogeneous binding sites and high affinity for target molecules. Integrating MOFs could help the performance of sensors with the desired stability and reproducibility. Electrochemical analysis revealed an observable enhancement of the output signal by the incorporation of MOF molecules, which is consistent with the sensitivity-enhancing role of MOF by providing more anchoring sites for the attachment of the polymer texture to the electrode surface. This MOF-MIP sensor exhibited impressive linear dynamic ranges ranging from 0.1 to 1.0 pM for VIS, with detection limits in the low picomolar range. In addition, the MOF-MIP sensor offers high accuracy, selectivity and precision for the determination of VIS, with no interference observed from complex media of serum samples. Additionally, in this study, Analytical GREEnness metric (AGREE), Analytical GREEnness preparation (AGREEprep) and Blue Applicability Grade Index (BAGI) were used to calculate the green profile score.

Follow up of the prostate cancer treatment based on a novel sensing method for anti-prostate cancer drug (flutamide)

Simultaneous Determination of Methotrexate and Calcium Folinate with Electrochemical Method Based on a Poly-Absa/functionalized MWNTs Composite Film Modified Electrode

Electrochemical detection of anti-cancer drug flutamide in biological fluids with calcium molybdate/molybdenum oxide as an effective electrocatalyst

Unraveling the electrochemical properties of lanthanum cobaltite decorated halloysite nanotube nanocomposite: An advanced electrocatalyst for determination of flutamide in environmental samples

High Quality Au-carbon Nitride Catalyst for Monitoring of Anti-prostate Cancer Drug (Flutamide)

Rational construction of micro-plate-like iron oxide/aluminium oxide-fabricated screen-printed carbon electrode for the electrochemical detection of the antiandrogen drug

Nanomolar level detection of non-steroidal antiandrogen drug flutamide based on ZnMn2O4 nanoparticles decorated porous reduced graphene oxide nanocomposite electrode

The High Stability and Selectivity of Electrochemical Sensor Using Low-Cost Diamond Nanoparticles for the Detection of Anti-Cancer Drug Flutamide in Environmental Samples

A molecularly imprinted poly 2-aminophenol-gold nanoparticle-reduced graphene oxide composite for electrochemical determination of flutamide in environmental and biological samples

Synthesis of Ag nanoparticles for the electrochemical detection of anticancer drug flutamide

Using cerium (III) orthovanadate as an efficient catalyst for the electrochemical sensing of anti-prostate cancer drug (flutamide) in biological fluids

Synthesis and application of 0D/2D nanocomposite for the nanomolar level detection of antiandrogen drug

Fabrication of Sn-doped ZnO hexagonal micro discs anchored on rGO for electrochemical detection of anti-androgen drug flutamide in water and biological samples

Facile construction of binary metal oxide heterojunction with hexagonal boron nitride nanohybrid electrocatalyst for the detection of flutamide

Ternary MnFeZn layered double hydroxides as an efficient material for the electrochemical sensing of flutamide

Gold Nanoparticle Embedded on a Reduced Graphene Oxide/polypyrrole Nanocomposite: Voltammetric Sensing of Furazolidone and Flutamide

Therapeutic Monitoring of Flutamide Using Aggregated Surface Enhanced Raman Spectroscopy (SERS) Substrates

Optimization of Electrochemical Sensitivity in Anticancer Drug Quantification through ZnS@CNS Nanosheets: Synthesis via Accelerated Sonochemical Methodology

Electrochemical Detection of Melphalan in Biological Fluids Using a g-C3N4@ND-COOH@MoSe2 Modified Electrode Complemented by Molecular Docking Studies with Cellular Tumor Antigen P53

Development of a molecularly imprinted polymer-based electrochemical sensor with metal-organic frameworks for monitoring the antineoplastic drug vismodegib

A new and powerful electrochemical sensing platform based on MWCNTs@Fe3O4@CuAl2O4 for the determination of the anticancer agent Alpelisib in bulk and biological fluids